Peritoneal metastases are the leading cause of morbidity and mortality in high-grade serous ovarian cancer (HGSOC). Accumulating evidence suggests that mesothelial cells are an important component of the metastatic microenvironment in HGSOC. However, the mechanisms by which mesothelial cells promote metastasis are unclear. Here, we report that the HGSOC tumor-mesothelial niche was hypoxic, and hypoxic signaling enhanced collagen I deposition by mesothelial cells. Specifically, hypoxic signaling increased expression of lysyl oxidase (LOX) in mesothelial and ovarian cancer cells to promote collagen crosslinking and tumor cell invasion. The mesothelial niche was enriched with fibrillar collagen in human and murine omental metastases. Pharmacologic inhibition of LOX reduced tumor burden and collagen remodeling in murine omental metastases. These findings highlight an important role for hypoxia and mesothelial cells in the modification of the extracellular matrix and tumor invasion in HGSOC.
Introduction
Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the United States. Despite advances in surgical and cytotoxic therapies, 80% of patients with advanced HGSOC develop recurrent, chemoresistant disease, resulting in a 5-year survival rate of 30% (1) . The majority of women diagnosed with high-grade serous ovarian cancer (HGSOC) present with stage III or IV disease in which the tumor has disseminated beyond the ovaries and pelvic organs to the peritoneum and abdominal organs including the diaphragm, stomach, omentum, liver, and intestines. Peritoneal metastases significantly contribute to morbidity in patients with ovarian cancer as these tumors are numerous and often obstruct vital organs in the abdomen including the bowels (1) . In addition, peritoneal metastases are associated with the formation of ascites that contribute to morbidity by increasing intra-abdominal pressure, leading to impaired circulation and respiratory distress (1) . Therefore, understanding the fundamental mechanisms that drive ovarian peritoneal metastasis may lead to the development of effective therapies to reduce morbidity and mortality in patients with ovarian cancer. The metastatic microenvironment in ovarian cancer is complex and dynamic with multiple cell types that support ovarian cancer metastasis. Among these cell types, mesothelial cells play an important role in the peritoneal metastatic niche. When establishing peritoneal implants, disseminated ovarian cancer cells migrate toward, attach, invade, and proliferate into the mesothelial cell layer covering the surface of organs in abdominal cavity including the omentum, a common site for ovarian cancer metastasis (2) (3) (4) . Intraperitoneal injection of primary human peritoneal mesothelial cells with ovarian cancer cells increases peritoneal metastasis in immunodeficient mice compared with injection of tumor cells alone (5) . Mesothelial cells promote HGSOC tumor cell adhesion, proliferation, and invasion, indicating that mesothelial cells play an active role in ovarian peritoneal metastasis (6, 7) . However, little is known regarding the molecular mechanisms by which HGSOC tumor-mesothelial interactions promote metastasis.
Hypoxia, or low oxygen tensions, is a key molecular feature of the tumor microenvironment (TME) that governs the metastatic potential of tumor and stromal cells. Hypoxia develops from an imbalance between oxygen delivery and consumption. Oxygen delivery is impaired in solid tumors due to the abnormal vasculature that develops as a result of an imbalance between pro-and antiangiogenic signals. In addition, oxygen consumption rates are high in proliferating tumor and infiltrating immune cells, leading to hypoxic regions within the TME (8) . Hypoxia activates the hypoxia-inducible factor (HIF) signaling pathway in both tumor and stromal cells (9) . The prolyl hydroxylase enzymes 1, 2, and 3 (PHD1/2/3) and VHL negatively regulate the HIF signaling pathway under normoxic conditions by cooperatively targeting the hypoxia-inducible transcription factors HIF1 and HIF2 for proteasomal degradation (10) . Under hypoxic conditions, HIF1 and HIF2 are stabilized and coordinate the cellular response to hypoxia by activating gene expression programs that facilitate oxygen delivery and cellular adaptation to oxygen deprivation (10) . It is well established that HIF1 and HIF2 promote the metastatic potential of tumor cells by activating target genes that stimulate multiple steps within the metastatic cascade including immune evasion, invasion, migration, intravasation/extravasation, and establishment of the premetastatic niche (8) . Recent studies have shown that HIF1 and HIF2 can promote prometastatic properties of some tumor-stromal cell populations. Studies with macrophage-specific inactivation of HIF1 or HIF2 have revealed an important role for HIF signaling in mediating the protumorigenic properties of macrophages within multiple tumor models (11, 12) . In addition, HIF signaling mediates bidirectional signaling between breast cancer cells and MSCs to promote metastasis (13) . In contrast, fibroblast specific inactivation of HIF1 accelerated tumor growth in a murine breast cancer model (14) . Further knowledge regarding the role of HIF signaling in mediating tumor-stromal interactions within specific metastatic TME is needed to understand how to best target the hypoxic TME for cancer therapy.
In ovarian cancer, HIF1, HIF2, and hypoxic gene signatures in the primary tumor are associated with poor patient survival and reduced relapse-free survival (15, 16) . HIF signaling has been shown to promote cancer stem cell properties, chemoresistance, invasion/migration, immune tolerance, and angiogenesis in ovarian cancer cells in vitro (17) (18) (19) (20) (21) . However, the role of hypoxia and HIF signaling in mediating tumor-stromal interactions in HGSOC are not known.
Here we demonstrate that the omental metastatic microenvironment in HGSOC, a common site of ovarian cancer metastasis, is hypoxic and both tumor cells and mesothelial cells express HIF1 and HIF2. Importantly, hypoxia promotes extracellular collagen fiber deposition by mesothelial cells in a HIF1-and HIF2-dependent manner. In addition, collagen remodeling and HGSOC tumor cell invasion mediated by hypoxic mesothelial and HGSOC cells occurs in an HIF and lysyl oxidase (LOX)-dependent manner, respectively. Pharmacologic inhibition of LOX decreases peritoneal metastasis and collagen crosslinking in the omentum in a murine model of ovarian cancer peritoneal metastases, suggesting that LOX inhibition may be an effective strategy to inhibit HGSOC metastatic progression. These findings reveal a role for mesothelial cells in collagen deposition within the tumor microenvironment and identify the HIF/LOX signaling axis as a druggable therapeutic target to inhibit collagen remodeling and tumor progression in HGSOC peritoneal metastases.
Materials and Methods

Cell culture
HGSOC cancer cell lines OVCAR5 and OVCAR8 were purchased from the National Cancer Institute-Frederick DCTD tumor cell line repository. The LP-9 human peritoneal mesothelial cell line was obtained from Coriell Cell Repositories. Primary human mesothelial cells (PHMC) were derived from omentum of patients with benign disease as described previously (6) . All patients who participated in this study provided written informed consent for collection and research use of their materials and use of these samples was approved by the Washington University Institutional Review Board (IRB #201309050). The mouse ID8 ovarian cancer cell line was obtained from Dr. Katherine F. Roby (Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS; ref. 22 ). All cell lines were authenticated from the original source and were used within 6 months of receipt. In addition, cells were tested upon receipt for viability, cell morphology, and the presence of Mycoplasma and viruses (Charles River Laboratories).
HGSOC cell lines OVCAR8 and OVCAR5 and the murine ID8 cell line were cultured in DMEM supplemented with 10% FBS. PHMC and LP-9 were cultured in media containing 45% Ham's F-12, 45% Medium M199, 10% FBS, 0.4 mg/mL hydrocortisone, and 20 ng/mL recombinant EGF. Tumor-mesothelial cell cocultures (OVCAR8þLP9 or OVCAR5þLP9) were cultured in DMEM supplemented with 10% FBS, 1% MEM vitamins, and 1% MEM nonessential amino acids.
Gene signature analysis
The gene expression data for computing the metastatic signature was obtained from GSE30587 (PMID: 24732363). There were 18 Affymetrix Human Gene 1.0 ST arrays corresponding to 9 primary and metastatic ovarian tumors. The arrays were normalized using the standard RMA algorithm. We performed a paired analysis of 9 primary ovarian cancers and their matched metastasis using nonparametric one-sided Wilcoxon signed-rank test. The full list of genes that are significantly increased in metastases can be found in Supplementary Table S1 . Previous work (PMID: 2786162) has identified genes that are induced under hypoxic conditions in ovarian cancer cells (GSE66894). Please see ref. 24 and Supplementary Table S6 for the complete list of genes that were hypoxia inducible. There were 3,478 unique genes that were induced >1.4-fold under hypoxic conditions with FDR-adjusted P < 0.05: this constitutes our set of hypoxic genes (23) . Overlap between the metastatic and hypoxic genes was assessed using a Fisher exact test. We identified 515 genes with significant overlap (Supplementary Table S2 ).
siRNA
Transient knockdown of nontargeting control, HIF1, HIF2, HIF1/HIF2, and LOX were achieved in 72 hours by transfection of 100 nmol/L ON-TARGET plus smart pool siRNA using DharmaFECT following manufacturer's protocols (Dharmacon). Cocultures plated at a density of 0.5 Â 10 6 cells per cell type were grown overnight in normoxia followed by transfection of the siRNAs. After 24 hours, the plates were cultured under normoxic and hypoxic conditions in serum-free media for 48 hours and conditioned media were collected.
Conditioned media
The serum-free conditioned media from the coculture plates grown under normoxic and hypoxic conditions were transferred to Amicon Ultra-15 Centrifugal Filter units through a 0.45-mm syringe filter and centrifuged at 4,000 rcf for 30 minutes. The conditioned media collected at the top of the filter was concentrated 10-fold by resuspending in serum-free media.
Collagen gels and confocal microscopy
The conditioned media was utilized to construct an in vitro 3D collagen matrix using Corning rat tail collagen I (3.57 mg/mL). Collagen fibril gels (1 mg/mL) were made from Type I rat tail collagen as described previously (24) and were imaged in reflection mode on a Leica SP5 scanning confocal microscope. Collagen fiber amount was calculated using MATLAB. See Supplementary Methods for detailed procedure.
Invasion assay
HGSOC cells were serum starved for 48 hours in normoxia. Matrigel invasion chambers with 8.0-mm pore membranes were primed with 500 mL of the conditioned media overnight in 37 C CO 2 incubator. Serum-starved cancer cells were plated on top of the control inserts or Matrigel invasion inserts and media containing 10% FBS was filled at the bottom of the inserts. Invasion inserts were stained and analyzed 24 hours later. Percent invasion through the Matrigel was normalized against the average number of cells that migrated through the control inserts.
Real-time qPCR
RNA extraction, reverse transcription, and real-time PCR analysis was performed as described previously (25) . Relative mRNA expression levels of the target genes were determined by normalizing against the corresponding mRNA levels of 18S. The sequences of human primer sets are summarized in Supplementary Table S3 .
Western blotting
Protein lysates from cells cultured in normoxia and hypoxia for 48 hours were harvested as described previously (26) . Antibodies HIF1, HIF2, P4HA1 (Novus Biologicals), COL1A1, LOX, P4HA3 (Abcam), P4HA2, PLOD2 (Abclonal), PLOD1 (Biorbyt), PLOD3 (Invitrogen), and HSP-70 (Sigma) were used. Horseradish peroxidase-conjugated secondary antibodies were probed for 1 hour at room temperature.
IHC
Paraffin-embedded tissue sections were deparaffinized and stained according to previously published protocols (27) . Primary antibodies HIF1 (anti-rabbit A300-286A; 1:100; Bethyl Laboratories), HIF2 (anti-rabbit NB100-122; 1:100; Novus Biologicals), LOX (anti-rabbit ab174316; 1:500; Abcam), and PIMO (anti-rabbit; 1:100; Hypoxyprobe) were used.
Immunofluorescence
Staining was performed following the protocol mentioned above. See detailed protocol in Supplementary Methods.
Picrosirius red staining
Collagen was stained by Picrosirius red as described in http:// www.ihcworld.com/_protocols/special_stains/sirius_red.htm.
Human normal and tumor omentum tissues
Human normal and tumor omentum were obtained from patients under IRB approval #201709191 in accordance with recognized ethical guidelines per the U.S. Common Rule.
Patients were treated at Washington University in St. Louis (St. Louis, MO) and written informed consent was obtained for tissue banking. Ovarian cancer metastatic tissue array containing 40 cores of metastatic cases in duplicates was obtained from US Biomax.
Peritoneal xenografts
Eight-week-old female NSG mice were randomized into saline or BAPN treatment groups (n ¼ 8). BAPN (100 mg/kg) or saline was administered intraperitoneally daily. OVCAR8 cells (1 Â 10 6 ) were injected intraperitoneally 3 days after BAPN pretreatment. After 5 weeks of BAPN treatment, the animals were euthanized and metastatic burden was determined.
For the murine ID8 model, 5 Â 10 6 ID8 cells were injected intraperitoneally into 8-week-old female C57BL/6 mice. Twentyeight days after tumor injection, mice were injected intraperitoneallywith75mg/kgofpimonidazole.Ninetyminuteslater,micewere euthanized and tissues were collected and fixed in 10% formalin.
All procedures for use of animals and their care were approved by the Institutional Animal Care and Use Committee of Stanford University in accordance with the institutional and NIH guidelines.
Second harmonic generation microscopy
Forty-micron-thick sections were sectioned using a vibratome (Leica) and the sections were imaged floating in PBS at Â100 magnification using SP8 DIVE FALCON SHG (second harmonic generation) microscope (Leica). Tile scanning and Z-stacks were performed using Leica software and the images are presented as extended depth of field merge of the Z-stacks. Collagen fiber amount in the tumor-bearing omentum was calculated for three regions of interest (ROI) per image.
Statistical analysis
Statistical significance was computed using GraphPad Prism. Two-way ANOVA and two-tailed unpaired t tests were performed. P < 0.05 ( Ã ) was considered statistically significant.
Results
HIF signaling is active and associated with hypoxia in the ovarian cancer metastatic microenvironment To determine whether hypoxic signaling influences HGSOC tumor-mesothelial interactions in the metastatic microenvironment, we first examined whether hypoxic signaling is active within the human HGSOC omental metastatic microenvironment. For this purpose, we examined whether hypoxic gene signatures are expressed in HGSOC metastatic gene signatures. Retrospective analysis of primary and matched metastases in a cohort of patients with HGSOC who were chemotherapy na€ ve (n ¼ 9) showed that 2,431 genes were differentially overexpressed in metastatic tumors compared with matched primary tumors ( Fig. 1A, Table S2) . These findings suggest a link between hypoxic signaling and the HGSOC metastatic microenvironment. Functional gene enrichment analysis of the 515 genes that overlap between hypoxic and HGSOC metastatic gene signatures using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database revealed that there were multiple genes involved in extracellular matrix organization, collagen catabolic processes, extracellular matrix disassembly, and collagen fibril organization (Fig. 1A) .
We next performed IHC analysis of the hypoxia-inducible transcription factors HIF1 and HIF2 in benign human omentum (n ¼ 3) and HGSOC omental metastases (n ¼ 40) to determine whether HIF1 and HIF2 are expressed within HGSOC omental metastases. We observed basal levels of HIF1 and HIF2 staining within benign human omentum that were significantly increased in HGSOC omental metastatic lesions (Fig. 1B and C) . HIF1 and HIF2 staining within HGSOC omental metastases was observed in both tumor and stromal cells (Fig. 1B) . We next examined whether the stabilization of HIF1 and HIF2 in ovarian omental metastases was associated with a hypoxic microenvironment. The ID8 murine model of ovarian metastasis was used to directly examine the hypoxic status of the omental metastatic microenvironment (22) . We used the hypoxic probe pimonidazole (PIMO) as a hypoxic cell marker to profile regions of hypoxia in the omentum of na€ ve and ID8 ovarian tumor-bearing C57BL/6 mice. At oxygen tensions below 1%, pimonidazole forms protein adducts that can be efficiently detected by IHC analysis (29) . As a positive control, pimonidazole adducts were readily detectable in hypoxic regions of the central vein of the liver (Supplementary Fig.  S1A ; ref. 30 ). In the omentum, pimonidazole adducts were detected at basal levels throughout the na€ ve omentum and increased in the tissue during metastatic tumor progression from 72 hours to 28 days after peritoneal tumor cell inoculation ( Fig. 1D and E; Supplementary Fig. S1A ). Pimonidazole staining within the total tumor-bearing omentum at late stages (28 days) of disease increased (Fig. 1D) . Interestingly, the pattern of PIMO staining was increased near the periphery of the omental metastatic tissue compared with the na€ ve omentum (Fig. 1D) . Regions of pimonidazole staining in the ID8 tumor-bearing omentum overlapped with regions of HIF1 and HIF2 expression (Supplementary Fig. S1B ). Our findings indicate that the metastatic microenvironment in ovarian omental metastases is hypoxic and expresses HIF1 and HIF2.
As mesothelial cells are a key cellular component of the HGSOC metastatic microenvironment, we next sought to determine whether mesothelial cells express HIF1 and/or HIF2. Immunofluorescence analysis of HIF1, HIF2, and the mesothelial cell marker calretinin in HGSOC omental metastases demonstrated that mesothelial cells express HIF1 and HIF2 in HGSOC omental metastases ( Fig. 2A; ref. 31 ). Western blot analysis for HIF1 and HIF2 confirmed that both PHMCs isolated from omentum and the LP-9 peritoneal mesothelial cell line derived from ascites fluid from a patient with HGSOC express HIF1 and HIF2 under hypoxic conditions ( Fig. 2B; ref. 32) . Moreover, the HIF1 and HIF2 targets including PGK1 and VEGFA were induced upon hypoxia treatment ( Fig. 2B; ref. 33 ). In addition to mesothelial cells, HGSOC cells express HIF1 and HIF2 upon hypoxic treatment in vitro and in HGSOC metastases ( Fig. 2A and C ). These findings demonstrate that HIF1 and HIF2 are expressed in both mesothelial and tumor cells within the HGSOC tumor-mesothelial microenvironment and cell lines.
Mesothelial cells express collagen type I and induce collagen secretion in a HIF-dependent manner We next sought to investigate the functional role of hypoxia and HIF signaling in regulating mesothelial and HGSOC tumor functions. Our analysis of metastatic and hypoxic gene expression profiles in Fig. 1A suggests that hypoxic signaling may influence collagen matrix organization in HGSOC metastases. Enhanced collagen type I deposition has recently been associated with increased tumor burden in HGSOC metastases (34) . In addition, collagen remodeling into long collagen bundles is correlated with tumor burden in HGSOC metastases (34) . Moreover, collagen remodeling signatures are associated with poor patient survival in HGSOC (35) . However, the cellular and molecular mechanisms that drive collagen deposition and remodeling in the HGSOC metastatic microenvironment are not known.
Here we investigated whether mesothelial and/or HGSOC tumor cells contribute to enhanced collagen deposition and remodeling in HGSOC metastases. We first analyzed benign human and HGSOC tumor-bearing omentum for collagen deposition by Picrosirius red staining (36) . Consistent with previous reports, we observed that collagen type I deposition increased in the human tumor-bearing omentum compared with the benign omentum ( Fig. 3A; ref. 34 ). Moreover, we observed increased collagen type I deposition by Picrosirius red staining within the omentum of C57BL/6 mice bearing ID8 ovarian tumors compared with na€ ve omentum (Fig. 3B) . Picro Sirius red staining within the human and mouse tumor-bearing omentum showed increased collagen fiber deposition within regions where the tumor was adjacent to the omentum surface ( Fig. 3A and B) . To determine whether there is enhanced COL1A1 expression in mesothelial cells of HGSOC compared with mesothelial cells in na€ ve omentum, we performed immunofluorescence analysis for calretinin-positive mesothelial cells and collagen type I (COL1A1) within human benign and HGSOC omentum. Calretinin-positive mesothelial cells produced more COL1A1 fibers in HGSOC omentum compared with the benign human omentum, suggesting that mesothelial cells contribute to enhanced collagen deposition within HGSOC omental metastases (Fig. 3C) . Immunofluorescence analysis of COL1A1 in normoxic and hypoxic HGSOC tumormesothelial cell cocultures confirmed that calretinin-positive mesothelial cells, but not calretinin-negative tumor cells, produce COL1A1 in vitro (Fig. 3D) . Interestingly, most of the type I collagen was intracellular in mesothelial cells under normoxic conditions, whereas under hypoxic conditions the type I collagen produced by mesothelial cells was deposited in the extracellular space into long fibers (Fig. 3D) . We next compared the relative expression of COL1A1 mRNA in human mesothelial cells (PHMC and LP-9) and HGSOC (OVCAR5 and OVCAR8) cells under normoxic and hypoxic conditions. We observed very low, almost undetectable, levels of COL1A1 in OVCAR5 and OVCAR8 cells under normoxic and hypoxic conditions (Fig. 3E) . In contrast, we observed robust expression of COL1A1 in human PHMC and LP-9 cells (Fig. 3E) . COL1A1 Hypoxia promotes collagen remodeling and invasion mediated by HGSOC tumor-mesothelial cocultures in a HIF1-and HIF2-dependent manner. A, Representative confocal images of collagen fibers from 3D collagen gels constructed using conditioned media from cocultures of OVCAR8 þ LP-9 and OVCAR5 þ LP-9 exposed to normoxia (21%) and hypoxia (2%) that were treated either with siRNA targeting HIF1 and HIF2 or siRNA targeting the scrambled control. Graphs show the corresponding quantification of the percentage volume of fiber amounts. Scale bar, 75 mm; n ¼ 3. B, Matrigel invasion assays of OVCAR8 or OVCAR5 cells through Matrigel inserts primed with conditioned media from cocultures of OVCAR8 þ LP-9 and OVCAR5 þ LP-9 exposed to normoxia (21%) and hypoxia (2%) that were treated either with siRNA targeting HIF1 and HIF2 or siControl. Scale bar, 75 mm; n ¼ 3. Graphs represent the normalized percentage of invading cells per field. Error bars, SD of the mean. Ã , P < 0.05.
mRNA expression was not changed under hypoxic conditions compared with normoxic conditions within human mesothelial cells (Fig. 3E) . Western blot analysis of conditioned media collected from normoxic and hypoxic mesothelial cell (LP-9, PHMC) or HGSOC cancer (OVCAR8, OVCAR5) cultures confirmed that mesothelial cells, but not HGSOC cells, secrete type I collagen (Fig. 3F) . Interestingly, COL1A1 secretion in mesothelial cells was enhanced under hypoxic conditions. Collectively, our findings indicate that mesothelial cells contribute to collagen type I deposition in HGSOC and collagen type I secretion by mesothelial cells is enhanced under hypoxic conditions. The molecular mechanisms driving collagen synthesis and the formation of covalent cross-linked collagen fibrils within the extracellular matrix are complex (37) . Previous studies have demonstrated that hypoxia and HIF signaling can promote the synthesis and stability of fibril-forming collagen through the upregulation of the intracellular enzymes including collagen prolyl 4-hydroxylases (P4HA1 and P4HA2) and lysyl hydroxylases (PLOD1 and PLOD2; refs. [38] [39] [40] [41] [42] . Strikingly, we found a number of these factors in the overlapping hypoxic and HGSOC metastatic gene signatures (pathways highlighted in Fig. 1A) . STRING network analysis of the genes within these pathways revealed protein-protein interactions among multiple collagen family members as well as enzymes involved in fibrillar collagen synthesis and remodeling ( Supplementary Fig. S2A ). Therefore, we examined the relative expression of these factors within human mesothelial (PHMC, LP-9) cells under normoxic and hypoxic conditions. While the expression of COL1A1 was not increased under hypoxia, the expression of intracellular enzymes responsible for collagen biogenesis (P4HA1, P4HA2, P4HA3) and their mechanical stability (PLOD1 and PLOD2) were significantly induced at the mRNA level by hypoxia compared with normoxia within mesothelial cells ( Fig. 3E; Supplementary Fig. S2B and  S2C ). Western blot analysis confirmed a hypoxic induction at the protein level of P4HA1 and P4HA3 in PHMC as well as PLOD2 in both PHMC and LP9 cells in hypoxic mesothelial cells compared with normoxic mesothelial cells ( Supplementary Fig. S2D and  S2E ). These findings demonstrate that the hypoxic induction of extracellular collagen deposition by human mesothelial cells is associated with the upregulation of collagen biogenesis and stability enzymes.
To determine whether hypoxia promotes collagen deposition by mesothelial cells in an HIF1 and HIF2-dependent manner, we treated human HGSOC and peritoneal mesothelial cells (OVCAR8 and LP-9) with siControl or siHIF1 and siHIF2 smart pools and cocultured the cells under normoxic or hypoxic conditions for 48 hours. Immunofluorescence microscopy of the siControl cocultures confirmed our previous findings that mesothelial cells are the source of type I collagen and collagen deposition by mesothelial cells is increased under hypoxic conditions (Fig. 3G ). In comparison with the siControl cocultures, the siHIF1/HIF2 cocultures had reduced type I collagen fibers under hypoxic conditions (Fig. 3G) . Western blot analysis of conditioned media collected from normoxic and hypoxic HGSOC tumor and mesothelial cell cocultures confirmed that the hypoxic secretion of collagen type I by mesothelial cells in HGSOC tumor-mesothelial cocultures occurs in a HIF1 and HIF2-dependent manner (Fig. 3H) . These findings suggest that hypoxic signaling mediated by HIF1 and HIF2 contributes to enhanced collagen deposition by mesothelial cells.
Tumor-mesothelial cocultures enhance extracellular collagen type I remodeling in a HIF-dependent manner
Once collagen is secreted into the extracellular space, collagen fiber formation is mediated by the LOX family of collagen crosslinking enzymes. In breast cancer, collagen crosslinking and fiber formation mediated by LOX family members promotes tumor cell invasion and metastasis (43, 44) . Collagen fibril organization pathways were enriched in the overlapping metastatic and hypoxic HGSOC gene expression analysis performed in Fig. 1 . Therefore, we examined the ability of conditioned media collected from normoxic and hypoxic HGSOC tumor-mesothelial cocultures to modify collagen crosslinking. Type I collagen was incubated with conditioned media from OVCAR5 or OVCAR8 and LP-9 cocultures that were treated with siControl or siHIF1 and siHIF2 smart pools and incubated under normoxic or hypoxic conditions. Reflection confocal microscopy showed that the conditioned media from hypoxic cocultures significantly increased the percentage of collagen type I fibers in a HIF1 and HIF2-dependent manner (Fig. 4A) .
We next hypothesized that HIF-mediated collagen remodeling mediated by secreted factors within HGSOC tumormesothelial cocultures may promote HGSOC tumor invasion. We examined whether the conditioned media from normoxic or hypoxic tumor-mesothelial cocultures enhanced HGSOC invasion in a HIF-dependent manner. HGSOC tumor cell invasion through Matrigel inserts primed with conditioned media from siControl or siHIF1/siHIF2-treated tumor (OVCAR8 or OVCAR5)-mesothelial (LP-9) cocultures revealed that hypoxic conditioned media facilitated the invasion of OVCAR5 and OVCAR8 HGSOC cells in an HIF1-and HIF2-dependent manner (Fig. 4B ). These findings demonstrate that hypoxic signaling in tumor-mesothelial cocultures results in the production of secreted factors that promote collagen fiber formation and tumor cell invasion in a HIF1-and HIF2-dependent manner. Hypoxia upregulates LOX in both tumor and mesothelial cells in a HIF-dependent manner. A, IHC staining of benign human omentum (n ¼ 3) and HGSOC omental metastases (n ¼ 40) for LOX. Scale bars, 100 mm. Graph shows the quantification of the percentage area positive for LOX in the benign and metastatic human omentum. B, Immunofluorescent staining of two different patient tissue sections of benign and tumor omentum for calretinin and LOX. Calretinin, green; LOX, red; DAPI, blue. Scale bar, 100 mm. Arrows, mesothelial lining of the omentum. Asterisks, tumor deposits. C, Real-time quantitative PCR analysis of LOX expression in OVCAR8 and LP-9 cells exposed to normoxic (21%) and hypoxic (2%) culture conditions that were treated with siRNA pools against control, HIF1 and HIF2 targeting sequences (n ¼ 3). Error bars, SD of the mean. Ã , P < 0.05. D, Western blot analysis of LOX expression in OVCAR8 and LP-9 cells. Western blots also confirm the downregulation of HIF1 and HIF2 in both the models (OVCAR8 and LP-9) upon treatment with siHIF1/siHIF2. HSP-70 was used as the protein-loading control. E, Immunofluorescent staining of cocultures of OVCAR8 and LP-9 cells cultured under normoxic (21%) and hypoxic (2%) conditions that were treated with siRNA pools targeting HIF1 and HIF2 or scrambled control. Images are representative of three biologic and three technical replicates. Calretinin, green; LOX, red; DAPI, blue. Scale bar, 100 mm.
Hypoxic mesothelial and HGSOC tumor cells upregulate LOX in a HIF-dependent manner to promote collagen remodeling and tumor invasion
We next sought to identify druggable downstream targets of HIF1 and HIF2 within the secreted tumor-mesothelial cocultures that promote HGSOC collagen fiber formation, tumor invasion, and metastasis. Analysis of the overlapping metastatic and hypoxic genes identified multiple LOX family members known to mediate collagen fiber formation (Supplementary Fig. S2A ). LOX is a secreted amine oxidase and a druggable target that mediates the covalent crosslinking of collagen and elastin within the extracellular matrix (45) . Recent studies have shown that LOX expression is associated with ovarian cancer metastasis, chemoresistance, and poor survival (35, 46, 47) . However, the role of LOX in mediating collagen remodeling and tumor progression within metastatic sites in ovarian cancer is not known. We found that LOX is highly expressed within HGSOC omental metastases compared with benign human omentum (Fig. 5A) . Moreover, immunofluorescent staining for LOX and calretinin in benign and HGSOC metastatic omentum revealed that LOX is expressed by both tumor cells and mesothelial cells (Fig. 5B) . To determine whether LOX is a HIF1 and HIF2 target in HGSOC tumor and/or mesothelial cells, we exposed HGSOC and human mesothelial cells to normoxic or hypoxic conditions. LOX was significantly induced at the mRNA and protein level in both hypoxic HGSOC (OVCAR5, OVCAR8) and human mesothelial cells (PHMC, LP-9) in an HIF1-and HIF2-dependent manner ( Fig. 5C and D; Supplementary Fig. S3A-S3D ). We further confirmed the HIF-dependent hypoxic induction of LOX in cocultures of OVCAR8 and LP-9 by immunofluorescent staining for LOX. Costaining of LOX with the mesothelial cell marker calretinin in the OVCAR8 þ LP-9 cocultures revealed LOX expression in both calretinin-positive mesothelial cells and calretinin-negative tumor cells (Fig. 5E ). LOX expression in these cells was induced upon hypoxic conditions in a HIFdependent manner (Fig. 5E ). These findings demonstrate that HIF1 and HIF2 are required for the hypoxic upregulation of LOX in the HGSOC tumor and mesothelial cells.
To determine whether LOX is an important factor contributing to hypoxia-induced collagen fiber remodeling and invasion within HGSOC tumor and/or mesothelial cells, we first investigated whether genetic inactivation of LOX is sufficient to reduce collagen type I fiber formation under normoxic and hypoxic conditions in HGSOC tumor-mesothelial cocultures. Genetic inhibition of LOX using siRNA smart pools in HGSOC tumor (OVCAR5 or OVCAR8) and mesothelial cell (LP-9) cocultures significantly inhibited the ability of conditioned media to promote type I collagen fiber formation under hypoxic conditions ( Fig. 6A ; Supplementary Fig. S4A and S4B ). We next investigated whether single cultures of HGSOC tumor (OVCAR8) or mesothelial (LP-9) cells enhance collagen remodeling under hypoxic conditions. Conditioned media from both HGSOC tumor (OVCAR8) or mesothelial (LP-9) cells independently increased the percentage of collagen type I fibers under hypoxic conditions compared with normoxic conditions. Similar to the HGSOC tumor-mesothelial cocultures, the hypoxic induction of collagen type I fiber formation occurred in a LOX-dependent manner within HGSOC and mesothelial cell single cultures ( Fig. 6A; Supplementary Fig. S4A ). These findings are consistent with data in Fig. 5C -E demonstrating that both HGSOC tumor and mesothelial cells increase LOX expression under hypoxic conditions. Given that collagen fiber formation can promote tumor cell invasion, we next examined whether conditioned media from normoxic or hypoxic HGSOC tumor, mesothelial, or tumor-mesothelial cocultures are sufficient to precondition Matrigel substrate to facilitate HGSOC tumor cell invasion in a LOX-dependent manner. Genetic inactivation of LOX significantly reduced the ability of conditioned media collected from hypoxic HGSOC, mesothelial and tumor-mesothelial cocultures to promote HGSOC invasion compared with the HGSOC invasion mediated by conditioned media from the corresponding siControl cultures ( Fig. 6B; Supplementary Fig. S4C ). These findings demonstrate that LOX is an important secreted factor driving collagen remodeling and tumor invasion mediated by HGSOC tumor and mesothelial cells.
Therapeutic inhibition of LOX inhibits metastatic ovarian cancer progression in vivo
The findings above identify a role for LOX in facilitating collagen remodeling and tumor invasion mediated by HGSOC tumor and mesothelial cells, raising the intriguing possibility that therapeutic inhibition of LOX may be an effective strategy for the treatment of metastatic HGSOC. Several classes of LOX inhibitors have been developed and have shown efficacy in preclinical models of metastasis including the small-molecule inhibitor of LOX enzymatic activity b -aminopropionitrile (BAPN; ref. 45 ). We first examined whether pharmacologic inhibition of LOX using BAPN is sufficient to inhibit collagen remodeling and HGSOC tumor cell invasion mediated by HGSOC tumor-mesothelial cell cocultures in vitro. BAPN treatment of HGSOC tumor (OVCAR5 or OVCAR8) and mesothelial (LP-9) cocultures significantly reduced type I collagen fiber formation induced by conditioned media collected from hypoxic cocultures (Fig. 7A) . Moreover, BAPN treatment significantly reduced the ability of HGSOC (OVCAR5 or OVCAR8) and LP-9 coculture conditioned media to stimulate HGSOC cell invasion through preconditioned Matrigel substrates (Fig. 7B) . To determine the efficacy of BAPN in metastatic HGSOC, we treated mice harboring OVCAR8 human HGSOC tumors with BAPN (100 mg/kg) or saline daily for 5 weeks. BAPN treatment resulted in a significant reduction in the number of peritoneal tumor nodules and total tumor weight compared with saline treatment (Fig. 7C) . No significant changes in body weight were observed between BAPN-treated and saline-treated mice during the study (Supplementary Fig.  S5 ). Consistent with our findings that LOX activity drives collagen remodeling within the HGSOC tumor-mesothelial cocultures, BAPN-treated tumor omentum had significantly reduced collagen fiber amount compared with saline-treated tumor omentum as determined by SHG microscopy (Fig. 7D ). These studies demonstrate that pharmacologic inhibition of LOX activity is an effective strategy to inhibit HGSOC progression and collagen remodeling in the metastatic HGSOC tumor microenvironment.
Discussion
Here we show that mesothelial cells are a cellular source of type I collagen in the HGSOC metastatic microenvironment and they facilitate HGSOC invasion through the secretion of the collagen remodeling enzyme LOX. Our data suggest a model where mesothelial cells lining the omentum interact with disseminated HGSOC cancer cells in a hypoxic microenvironment. Hypoxia results in the stabilization of the hypoxicinducible transcription factors HIF1 and HIF2 in both mesothelial and tumor cells. Hypoxic signaling preferentially upregulates the expression of factors involved in collagen biogenesis, stability (P4HA1, P4HA2, P4HA3, PLOD1, PLOD2) and collagen remodeling (LOX) within collagen type I expressing mesothelial cells to promote extracellular collagen deposition and remodeling. Hypoxic cancer cells further contribute to the remodeling of the extracellular collagen through the upregulation of LOX. Collectively, enhanced collagen type I remodeling by HGSOC tumor and mesothelial cells enhances HGSOC tumor invasion in a HIF-and LOX-dependent manner. These findings identify a role for mesothelial cells in collagen deposition and collagen remodeling within the HGSOC metastatic microenvironment. Figure 6 . LOX expression by HGSOC tumor and mesothelial cells promotes collagen remodeling and invasion under hypoxic conditions. A, Quantification of the percentage volume of fiber amounts (top) and representative confocal collagen fiber images of 3D collagen gels (bottom) casted using conditioned media from OVCAR8 cultured alone, LP-9 cultured alone, and cocultures of OVCAR8 þ LP-9 exposed to normoxia (21%) and hypoxia (2%) that were treated either with siRNA targeting LOX or siControl. Scale bar, 75 mm; n ¼ 3. B, Graphical illustration of the percentage invasion and their representative images of OVCAR8 cells invading through Matrigel inserts primed with conditioned media from OVCAR8 cultured alone, LP-9 cultured alone, and cocultures of OVCAR8 þ LP-9 exposed to normoxia (21%) and hypoxia (2%) that were treated either with siRNA pools targeting LOX or siControl. Scale bar, 75 mm; n ¼ 3. Graph represents the normalized percentage of invading cells per field. Error bars, SD of the mean. Ã , P < 0.05.
Collagen deposition and cross-linking plays an important role in metastatic tumor initiation and progression. Collagen deposition and remodeling in the extracellular matrix can directly promote tumor proliferation, evasion of growth suppression, death resistance, replicative immortality and invasion by engaging collagen receptors (DDR1, DDR2) as well as integrins (48) . In addition, collagen deposition in the ECM can inhibit T-cell function and promote angiogenesis to facilitate tumor progression (48) . In HGSOC, collagen-remodeling gene signatures are associated with metastasis and poor patient survival (34, 35) . Grither and colleagues recently showed that the collagen receptor DDR2 is associated with poor survival in patients with HGSOC. Moreover, DDR2 signaling on HGSOC cells drives tumor cell mesothelial cell clearance, invasion through collagen type I, and metastasis in vivo, highlighting the importance of collagen receptor signaling in mediating HGSOC tumor invasion and metastasis in the metastatic microenvironment (49) . However, the cellular and molecular mechanisms driving collagen remodeling in the HGSOC metastatic microenvironment remains largely unknown. Here we demonstrate that mesothelial cells are a cellular source of collagen type I in the HGSOC metastatic microenvironment. Moreover, our findings suggest that the hypoxic tumor-mesothelial niche in HGSOC metastatic microenvironment may enhance collagen deposition and remodeling to facilitate the early stages of tumor cell invasion and metastasis.
Hypoxia and HIF signaling has a well-established role in promoting the hematogenous spread of cancer cells to distant tissue sites including the lung, liver, and bone. At these distant tissue sites, hypoxia and HIF signaling play an important role in establishing the premetastatic niche, modulation of tumor- Figure 7 . Therapeutic inhibition of LOX inhibits metastatic ovarian cancer progression in vivo. A, Representative confocal images of collagen fibers from 3D collagen gels constructed using conditioned media from cocultures of OVCAR8 þ LP-9 and OVCAR5 þ LP-9 exposed to normoxic (21%) or hypoxic (2%) conditions treated with saline or the LOX inhibitor BAPN. Graphs show the corresponding quantification of the percentage volume of fiber amounts. Scale bar, 75 mm; n ¼ 3. B, Matrigel invasion assays of OVCAR8 or OVCAR5 cells through Matrigel inserts primed with conditioned media from cocultures of OVCAR8 þ LP-9 or OVCAR5 þ LP-9 exposed to normoxic (21%) or hypoxic (2%) conditions that were treated with saline or BAPN. Scale bar, 75 mm; n ¼ 3. Graphs represent the normalized percentage of invading cells per field. C, Representative images showing metastatic tumor burden in 8-week-old female NSG mice that were intraperitoneally injected with OVCAR8 cells and treated either with saline or BAPN (n ¼ 8 per treatment group). Graphical representation of tumor weight and tumor nodules in the mice administered with saline or BAPN. D, Representative SHG microscopy images of collagen fibrils from the omentum of mice that were injected intraperitoneally with OVCAR8 cells and treated with saline or BAPN. The graph shows MATLAB quantification of the percentage volume of fiber amount in the omentum of saline or BAPN-treated mice (n ¼ 2 per treatment group; three ROIs per image were quantified). Error bars, SD of the mean.
endothelial and endothelial-endothelial interactions to facilitate tumor extravasation from the vasculature, and metabolic adaptation of tumor cells (8) . However, the role of hypoxia and HIF signaling in the transcoelomic spread of disseminated tumor cells within the peritoneal fluid to mesothelial lined peritoneal organs has not been investigated. Here we demonstrate that the HGSOC omental metastatic microenvironment is hypoxic where both tumor and mesothelial cells express HIF1 and HIF2 to facilitate the early stages of metastasis and tumor invasion. These findings identify an important role for hypoxia in mediating tumormesothelial interactions to support peritoneal metastasis.
Our findings have important clinical implications for the treatment of HGSOC. The overall survival rate of patients with HGSOC has not significantly changed over the past several decades (50) . Surgery and platinum-based chemotherapy are the standard treatments for HGSOC. Despite the initial efficacy of these treatments, 80% of women diagnosed with advanced HGSOC will develop recurrent chemoresistant disease. For these reasons, efforts are focused on the development of targeted therapies to improve survival rates in women with advanced HGSOC. Our data suggest that anti-LOX treatment might be a clinically effective treatment strategy in HGSOC. The model of metastatic progression in our studies resembles the development of recurrent disease in patients with HGSOC following surgical debulking. We found that targeting LOX enzymatic activity as a single-agent therapy is sufficient to reduce peritoneal metastasis and collagen remodeling at the omentum in immunodeficient murine models of HGSOC. These findings suggest that anti-LOXtargeting agents may be an effective strategy to prevent or delay the development of tumor recurrence in metastatic HGSOC. In summary, our studies identify LOX as a druggable molecular target driving collagen remodeling and metastatic progression in HGSOC. These studies provide preclinical data to support the development of LOX inhibitors for the treatment of HGSOC.
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